Comparing the efficacy and safety of direct oral anticoagulants with warfarin in the morbidly obese population with atrial fibrillation

K Kido, S Ngorsuraches - Annals of Pharmacotherapy, 2019 - journals.sagepub.com
Background: The International Society of Thrombosis and Haemostasis recommends
avoiding direct oral anticoagulants (DOACs) in morbidly obese patients with a body mass …
被引用次数：88 相关文章

Comparing the Efficacy and Safety of Direct Oral Anticoagulants With Warfarin in the Morbidly Obese Population With Atrial Fibrillation

K Kido, S Ngorsuraches - Annals of Pharmacotherapy, 2018 - cir.nii.ac.jp
抄録< jats: p> Background: The International Society of Thrombosis and Haemostasis
recommends avoiding direct oral anticoagulants (DOACs) in morbidly obese patients with a …

Comparing the Efficacy and Safety of Direct Oral Anticoagulants With Warfarin in the Morbidly Obese Population With Atrial Fibrillation

K Kido, S Ngorsuraches - The Annals of pharmacotherapy, 2019 - pubmed.ncbi.nlm.nih.gov
Background The International Society of Thrombosis and Haemostasis recommends
avoiding direct oral anticoagulants (DOACs) in morbidly obese patients with a body mass …

Comparing the Efficacy and Safety of Direct Oral Anticoagulants With Warfarin in the Morbidly Obese Population With Atrial Fibrillation.

K Kido, S Ngorsuraches - The Annals of Pharmacotherapy, 2018 - europepmc.org
Background The International Society of Thrombosis and Haemostasis recommends
avoiding direct oral anticoagulants (DOACs) in morbidly obese patients with a body mass …